Skip to main content
letter
. 2017 Aug 3;4:17031. doi: 10.1038/hgv.2017.31

Table 1. Clinical characteristics of the POLD1 mutation-caused MDPL patient presented here compared to previously described subjects.

Clinical features Study patient Previous studiesa (n=13)
Age (years; range, median) 11 10–62, 25
Sex Male 6 males, 7 females
Birth weight (kg; range, mean) 2.692 2.4–4.2, 3.23 (n=9)
Height (cm) 125.2
Weight (kg) 24.58
BMI (kg/m2; range, mean) 15.7 13.8–26.8, 17.5
     
Metabolic profile
 Diabetes mellitus N 5/13
 Hepatic steatosis Y 4/6
 ALT (U/l) 52 (5–40) Abnormal LFT 5/8
 Total cholesterol (mg/dl) 141 (130–220) High 8/10
 Triglycerides (mg/dl) 125 (35–150) High 9/11
 Leptin (ng/ml) 10.9 4.4–8.2, 5.6 (n=4)
     
Morphology
 Short stature Y 8/13
 Tight skin around cheeks and small nasal bones Y 13/13
 Mandibular underdevelopment Y 12/13
 Dental overcrowding/irregular teeth Y 10/13
 Telangiectasia N 9/13
 Thin arms and legs with wide trunk Y 13/13
High pitched voice Y 9/12
Hearing impairment Y 10/13
     
Musculoskeletal
 Joint contractures Y 5/13
 Muscle wasting Y 11/13
 Kyphosis/scoliosis N 4/5
Hypogonadism Y 4/5 males
Abnormal cognitive function N 1/12

Abbreviations: ALT, alanine aminotransferase; BMI, body mass index; LFT, liver function test; MDPL, mandibular hypoplasia, deafness, progeroid features and lipodystrophy; N, no; Y, yes.

a

Previously reported cases with POLD1 mutation-caused MDPL.